Contact
Privacy
DMCA
Robuta
https://avidicure.com/
Avidicure
Mar 2, 2026 - Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer